Full-Time

Associate Director

Enterprise Operations R&D

Confirmed live in the last 24 hours

Acadia Pharmaceuticals

Acadia Pharmaceuticals

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Senior

Princeton, NJ, USA + 1 more

More locations: San Diego, CA, USA

Hybrid model requires this role to work in the office three days per week on average.

Category
Lab & Research
Life Sciences
Medical Research
Required Skills
Word/Pages/Docs
Risk Management
Excel/Numbers/Sheets

You match the following Acadia Pharmaceuticals's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s degree in STEM, communications or other related field
  • Targeting 8 years of relevant progressive experience in the pharmaceutical/medical device industry with a focus in R&D scientific communications and/or project management experience
  • Project management certificate preferred (i.e. PMP, Six Sigma, etc.)
  • Clear and concise written and verbal communication to effectively convey scientific information across all levels of the organization
  • Ability to manage multiple tasks and priorities effectively
  • Adept at building strong relationships with internal and external stakeholders to facilitate collaboration
  • Experience working independently and highly detail oriented when developing, executing, and monitoring project plans to meet deadlines
  • Ability to handle sensitive information with utmost confidentiality
  • Ability to gather and interpret scientific data to inform decision-making
  • Self-organized, self-directing and highly motivated
  • Ability to identify opportunities and develop a plan to address challenges
  • In depth knowledge and skills in Microsoft Word, PowerPoint, Excel and Outlook
  • Ability to travel 25% of the time
Responsibilities
  • Assist the Chief of Staff of R&D in planning, executing, and monitoring strategic and special projects
  • Coordinate cross-functional teams to ensure alignment and timely completion of project milestones
  • Facilitate communication between stakeholders, including the Head of R&D and the R&D leadership team, to ensure clear understanding of project goals and progress
  • Prepare and maintain project documentation, including timelines, status reports, and meeting minutes
  • Identify and mitigate potential risks and issues that may impact project success
  • Support the development and implementation of strategic initiatives to achieve organizational goals
  • Conduct research in industry trends, market conditions, and potential opportunities relevant to the R&D organization strategy to inform decision-making and project planning
  • Assist in the preparation of scientific presentations and reports for senior leadership
  • Support chief of staff and head of R&D in planning and executing culture-building activities and events
  • Support executive scientific communications for the Head of R&D through social media and external-facing presentations, as well as internal newsletters and R&D townhalls
  • Develop R&D and pipeline-related content for a wide variety of audiences in partnership with the Chief of Staff for R&D, Investor Relations, and Corporate Communications
  • Strategize the R&D narrative and supporting materials, including working with internal colleagues to create molecule/mechanism of action/disease state images and videos for multipurpose use (e.g., pipeline/medical booths and medical congresses, investigator meetings, advisory boards)
  • Other duties as assigned
Desired Qualifications
  • Project management certificate preferred (i.e. PMP, Six Sigma, etc.)
Acadia Pharmaceuticals

Acadia Pharmaceuticals

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, which are then approved by regulatory bodies like the FDA before being sold to patients and healthcare providers. What sets Acadia apart from competitors is its commitment to addressing unmet medical needs in neuroscience, along with its focus on corporate social responsibility, including diversity and inclusion. The goal of Acadia Pharmaceuticals is to improve the quality of life for individuals suffering from challenging neurological diseases through effective treatments.

Company Size

501-1,000

Company Stage

Acquired

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's recent Health Canada approval for Daybue boosts its market presence in Canada.
  • The exclusive license agreement with Saniona expands Acadia's drug portfolio with SAN711.
  • Hiring Thomas Andrew Garner as CCO strengthens Acadia's commercial leadership team.

What critics are saying

  • Increased competition in CNS drugs may impact Acadia's market share and growth.
  • Regulatory challenges could delay or prevent new drug approvals, affecting revenue.
  • High drug development costs may strain financial resources if trials are unsuccessful.

What makes Acadia Pharmaceuticals unique

  • Acadia focuses on unmet needs in neurological disorders like Parkinson's and Rett syndrome.
  • The company has a strong R&D pipeline with four product candidates in development.
  • Acadia collaborates with partners like Biovail to enhance drug development and commercialization.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Company News

Fierce Pharma
Dec 9th, 2024
Acadia nabs Lexicon, Bristol Myers Squibb veteran as new commercial lead

Acadia Pharmaceuticals has hired Big Pharma veteran Thomas Andrew Garner as its new chief commercial officer (CCO).

MarketWatch
Nov 26th, 2024
Acadia Pharmaceuticals in Exclusive License Agreement With Saniona for SAN711

Acadia Pharmaceuticals on Tuesday said it entered into an exclusive worldwide license agreement with Saniona to develop and commercialize SAN711.

World Pharmaceuticals
Oct 17th, 2024
Acadia gets Health Canada approval for Daybue to treat Rett Syndrome

US-based biopharmaceutical company Acadia Pharmaceuticals has received Health Canada marketing authorisation for Daybue (trofinetide) to treat a rare genetic neurological disorder.

PRWeb
Aug 23rd, 2024
Global Genes' Annual Week In Rare Event Heading To Kansas City

"Week in RARE provides advocates a unique opportunity to participate in multiple events in one place to maximize their time, travel, and potential to gain benefits from their participation."

Yahoo Finance
Aug 15th, 2024
Ryan Reynolds Announces More To Parkinson'S(R) Campaign

Ryan & Tammy Reynolds (Photo: Business Wire)Acadia Parkinson's Fact Sheet-- The national disease awareness campaign aims to educate and drive conversation about recognizing and managing non-motor symptoms of Parkinson’s, including hallucinations and delusions-- Reynolds and his mother Tammy share their personal story about the impact of these symptoms on their familySAN DIEGO, August 14, 2024--(BUSINESS WIRE)--Ryan Reynolds, a world-renowned actor/entrepreneur and Parkinson’s disease advocate, with Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the launch of a multi-faceted disease education campaign, More to Parkinson’s®, to raise awareness among caregivers, patients and their care providers about a common, yet under-recognized aspect of Parkinson’s disease – Parkinson’s-related hallucinations and delusions.Notably, around half of the people living with Parkinson’s disease may develop hallucinations or delusions over the course of their disease, but up to 90% of people currently do not proactively tell their physicians about these symptoms.1-3 By sharing their experiences caring for Ryan’s father, James "Jim" Reynolds, who passed away nearly a decade ago, Ryan and his mother Tammy, aim to raise awareness, educate and drive conversation between people with Parkinson’s disease, their families and their doctors about how best to talk about and treat these non-motor symptoms."My father experienced hallucinations and delusions. At the time, we didn’t know any of these types of symptoms were part of his Parkinson’s disease," Reynolds explains. "Like a lot of caregivers, my mom mostly tried to carry these burdens alone. I wish I’d known Parkinson’s disease wasn’t limited to only motor symptoms. I think people and families affected by Parkinson’s can be better prepared to manage hallucinations and delusions if they’re talking early and often about this lesser-known aspect of the disease."This press release features multimedia